Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:32:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Results Submitted appears and a new revision (v3.4.2) is listed; the 'No Results Posted' notice was removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:26:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a Notice about government funding lapse and NIH Clinical Center operating status. Updated the page version from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:57:29.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The update includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' notice, and revision indicator (v3.4.0). Core study content, eligibility criteria, and results data remain unchanged.
    Difference
    0.1%
    Check dated 2026-01-28T04:22:05.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 instead of v3.3.3; this update does not modify study details, eligibility criteria, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:41:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section updated with a revised list of study sites, including additions and removals across the United States and international regions.
    Difference
    2%
    Check dated 2025-12-23T17:13:14.000Z thumbnail image

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.